Clinical studies recruiting near Meridian

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Saint Luke's Cancer Institute - Meridian · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996 A Long-Term Follow-Up Study of Participants Exposed to REACT
Phase N/A · Boise Kidney & Hypertension Institute · Prokidney · NCT05918523 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Idaho Urologic Institute-Meridian · Alliance for Clinical Trials in Oncology · NCT07321652 A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06594991 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Velocity Clinical Research - Boise · Amgen · NCT07037433 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Idaho Urologic Institute-Meridian · Alliance for Clinical Trials in Oncology · NCT07091617 Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · University of California, San Francisco · NCT05009992 Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
Phase 1/Phase 2 · Laminar Pharmaceuticals · NCT04299191 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Saint Luke's Cancer Institute - Meridian · NRG Oncology · NCT05174169 Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT04410796 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Idaho Urologic Institute-Meridian · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Saint Luke's Cancer Institute - Meridian · Alliance for Clinical Trials in Oncology · NCT06931340 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Ca
Phase 3 · Solaris Clinical Research · Amgen · NCT07575399 EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
NA · BrainQ Technologies Ltd. · NCT06386874 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Saint Luke's Cancer Institute - Meridian · Alliance for Clinical Trials in Oncology · NCT06876714 A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/
Phase 1 · Sanofi · NCT06630806 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atop
Phase 3 · Ada West Research · Organon and Co · NCT07265479 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Idaho Urologic Institute-Meridian · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Idaho Urologic Institute-Meridian · Canadian Cancer Trials Group · NCT06592924 Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving Psychological Health in People With Brain
NA · Hackensack Meridian Health · NCT07436754 Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
NA · Hackensack Meridian Health · NCT05651945 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Idaho Urologic Institute-Meridian · SWOG Cancer Research Network · NCT05806515 A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Velocity Clinical Research - Boise · Uniquity One (UNI) · NCT06496620 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Idaho Urologic Institute-Meridian · Alliance for Clinical Trials in Oncology · NCT04242095 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · Daiichi Sankyo · NCT06203210 Effect of Acupuncture on Mild to Moderate Active Crohn's Disease
NA · Shanghai Institute of Acupuncture, Moxibustion and Meridian · NCT04187820 A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Year
Phase 3 · Sanofi · NCT07285460 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Saint Luke's Cancer Institute - Meridian · National Cancer Institute (NCI) · NCT05256225 Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · Saint Luke's Cancer Institute - Meridian · National Cancer Institute (NCI) · NCT05554393

Look up another city

Look up another condition